Zerui Wu

3PUBLICATIONS
12CO-AUTHORS
Molecular targetsMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 14, 2026
LGALS3 Drives Dopamine Agonist Resistance in Prolactinoma by Activating the MAPK/ERK Pathway: A Multi-Omics Study.

|Sep 10, 2021
Surgery and Medical Treatment in Microprolactinoma: A Systematic Review and Meta-Analysis.

Jianglong Lu, Lin Cai, Zerui Wu

|Jul 05, 2021
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.

Zerui Wu, Yunqiu Xu, Jiadong Xu

Pageof 1

Frequent Collaborators

2 joint publications

Jiadong Xu

2 joint publications

Jianglong Lu

2 joint publications

Lin Cai

2 joint publications

Qun Li